CAR T-cell therapy, which has been successful in treating blood cancers, is now being explored for its potential to treat solid tumors. Researchers are working to develop more sensitive and effective forms of the therapy, with some studies showing promise in eliminating tumors in certain types of cancer, including pancreatic, ovarian, and kidney cancer. The therapy, which involves using a patient's own genetically modified cells, has been recognized for its revolutionary impact on cancer treatment.